Bills Biotech Pvt Revenue and Competitors

VADODARA, IND

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bills Biotech Pvt's estimated annual revenue is currently $5M per year.(i)
  • Bills Biotech Pvt's estimated revenue per employee is $77,500

Employee Data

  • Bills Biotech Pvt has 65 Employees.(i)
  • Bills Biotech Pvt grew their employee count by 3% last year.

Bills Biotech Pvt's People

NameTitleEmail/Phone
1
Managing DirectorReveal Email/Phone
2
Assistant ManagerReveal Email/Phone
3
Manager quality assuranceReveal Email/Phone
4
Quality Assurance ManagerReveal Email/Phone
5
EnvironmentReveal Email/Phone
6
Business DevelopmentReveal Email/Phone
7
Industrial AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is Bills Biotech Pvt?

Bills Biotech Pvt Ltd is an R&D based Biotechnology company, having focus on the fermentation based products. Since its inception in 2009, Bills Biotech has recorded an excellent growth through diversification and process improvements in anti obesity drug and having state-of-the-art fermentation and downstream department. Bills Biotech is a professionally managed globally recognized supplier of fermentation based API's & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bills Biotech Pvt News

2022-03-30 - Amber alert issued for severe lightning today (09)

Decision on non-payment of electricity bills today (17) ... government acts only for their own interests – Qingdao Seawin Biotech Group.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A660%N/A
#2
$8.3M66-23%N/A
#3
$9.3M71N/AN/A
#4
$5.7M7925%N/A
#5
N/A815%N/A